Loading...
01/11 03:43
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture. Financial performance shows improvement, with increased net revenues, gross profit, and reduced losses, yet color cosmetics face a decline, reflecting market challenges. Regulatory and supply chain issues persist, and management's responses lacked clarity, especially regarding product promotion and sales forecasts. The share repurchase program is a positive, but the absence of concrete guidance tempers optimism. Overall, the sentiment is neutral, as the positives are balanced by ongoing challenges and uncertainties.
Total Net Revenues RMB833.5 million (up 7.8% year-over-year); increase driven by a 47.7% rise in net revenues from skincare brands, partially offset by a 9.9% decrease in color cosmetics.
Gross Profit RMB659.1 million (up 9.7% year-over-year); increase attributed to higher sales of higher-gross-margin products.
Gross Margin 79.1% (up from 77.7% year-over-year); improvement driven by greater contribution from higher-margin products.
Total Operating Expenses RMB693.2 million (down 8.6% year-over-year); decrease due to cost management efforts.
Fulfillment Expenses RMB51.8 million (slightly up from RMB51.4 million year-over-year); as a percentage of total net revenues decreased to 6.2% from 6.7% due to improved logistics efficiency.
Selling and Marketing Expenses RMB553.8 million (up from RMB539.2 million year-over-year); as a percentage of total net revenues decreased to 66.4% from 69.7% due to more strategic marketing spending.
General and Administrative Expenses RMB64.9 million (down from RMB140.1 million year-over-year); as a percentage of total net revenues decreased to 7.8% from 18.1% due to lower share-based compensation and payroll expenses.
Research and Development Expenses $22.6 million (down from $27.9 million year-over-year); as a percentage of total net revenues decreased to 2.7% from 3.6% due to lower lease expenses and share-based compensation.
Loss from Operations $34.1 million (down from $157.7 million year-over-year); operating loss margin improved to 4.1% from 20.4%.
Net Loss $5.6 million (down from $124.9 million year-over-year); net loss margin improved to 0.7% from 16.1%.
Non-GAAP Net Income RMB7.1 million (turnaround from non-GAAP net loss of RMB83.8 million year-over-year); non-GAAP net income margin improved to 0.9% from a loss margin of 10.8%.
Cash and Short-term Investments RMB1.28 billion (down from RMB1.36 billion as of December 31, 2024); slight decrease.
Net Cash from Operating Activities $23.8 million (compared to net cash used of RMB121.6 million for the prior period); significant improvement.
New Product Launch: In May, we hosted an offline event in Greenland, China to officially launch the upgraded, rejuvenating Michaelmasque, which recently obtained the Special Cosmetic Registration Certificate for whitening products.
Product Performance: Galénic’s number one Vitamin C serum was the best-selling product in the premium vitamin serum category, while the secret de-oxidant active cream ranked among the top six anti-aging creams on Tmall.
Product Development: We launched the third Bakuchiol acne research project led by 14 renowned dermatologists, reaching over 20,000 doctors.
Market Growth: China’s beauty market saw modest growth in Q1 2025, with beauty retail sales rising 3.2% year-over-year.
Sales Performance: Total net revenues increased by 7.8% year-over-year, with skincare brands rising by 47.7%.
Cost Management: General and administrative expenses decreased to 7.8% of total net revenues, down from 18.1% a year ago.
Marketing Efficiency: Selling and marketing expenses as a percentage of total net revenues narrowed to 56.4% from 59.7%.
Share Repurchase Program: The Board approved a new share repurchase program to buy back up to $30 million worth of ordinary shares over the next 24 months.
Strategic Focus: The company is focused on accelerating growth for skincare brands and optimizing cost structure for profitable growth.
Market Conditions: The beauty market in China is experiencing modest growth, with beauty retail sales rising only 3.2% year-over-year, trailing behind the total retail sales growth of 4.6%. This indicates a competitive pressure and a challenging market environment.
Revenue Decline in Color Cosmetics: There was a 9.9% year-over-year decrease in net revenues from color cosmetics brands, which could indicate a shift in consumer preferences or increased competition in this segment.
Regulatory Challenges: The company mentioned obtaining a Special Cosmetic Registration Certificate for whitening products, highlighting the regulatory hurdles that can impact product launches and market entry.
Supply Chain and Fulfillment Costs: Fulfillment expenses remained relatively stable, but the company noted the need for improvements in logistics efficiency, indicating potential supply chain challenges.
Economic Factors: The overall economic environment remains complex, which could affect consumer spending and market dynamics in the beauty sector.
Strategic Marketing Spending: While the company has improved its marketing spending efficiency, the need for strategic marketing indicates ongoing challenges in effectively reaching consumers.
Strategic Initiatives: Yatsen is focused on accelerating growth for its skin care brands and optimizing its cost structure to prepare for profitable growth.
Share Repurchase Program: The Board of Directors approved a new share repurchase program to buy back up to $30 million worth of ordinary shares over the next 24 months, commencing on May 15, 2025.
R&D Focus: Yatsen emphasizes R&D as a core competitive advantage, with a global R&D center in Shanghai accredited by the China National Accreditation Service.
Revenue Guidance Q2 2025: Total net revenues are expected to be between RMB810.4 million and RMB889.9 million, representing a year-over-year increase of approximately 2% to 12%.
Profitability Outlook: The company aims to continue improving profitability through strategic marketing spending and cost management.
Cash Position: As of March 31, 2025, Yatsen had cash and short-term investments of RMB1.28 billion.
Share Repurchase Program: The Board of Directors has approved a new share repurchase program under which Yatsen may repurchase up to $30 million worth of its ordinary shares over the next 24 months, commencing on May 15, 2025.
The earnings call highlights strong financial performance, with significant revenue and gross profit growth, improved margins, and reduced losses. The Q&A section reveals optimism about profitability in Q4 and sustained growth through R&D and marketing optimization. Despite competition, the company's strategy to focus on high-end brands and innovation is promising. The lack of detailed guidance on expenses is a minor concern, but overall, the positive financial results and optimistic outlook suggest a positive stock price movement.
The earnings call reveals strong financial performance with increased gross margin, reduced operating losses, and a shift to non-GAAP net income. The strategic focus on high-margin skincare and R&D investments, alongside a share repurchase program, indicates confidence in future growth. Positive Q3 guidance for skincare and improved profitability strategies further bolster the outlook. Despite increased competition, the company's robust R&D capabilities and strategic initiatives suggest a positive trajectory. The Q&A section supports this with no significant concerns raised by analysts, reinforcing the positive sentiment.
The earnings call presents a mixed picture. Financial performance shows improvement, with increased net revenues, gross profit, and reduced losses, yet color cosmetics face a decline, reflecting market challenges. Regulatory and supply chain issues persist, and management's responses lacked clarity, especially regarding product promotion and sales forecasts. The share repurchase program is a positive, but the absence of concrete guidance tempers optimism. Overall, the sentiment is neutral, as the positives are balanced by ongoing challenges and uncertainties.
The earnings call reveals declining revenues and significant market challenges, particularly in the beauty sector. Despite improvements in gross margin and reduced net loss, the absence of a share repurchase program and liquidity concerns indicate financial instability. The Q&A section highlights vague responses, adding uncertainty. While there is optimistic guidance for Q4 2024, the negative sentiment from declining industry trends and strategic risks outweighs potential positives, leading to a likely negative stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
